Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 1/20 | 0.39 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6237184 | 0.97 | GLRA1 (0.37) | GLRA1SLC6A9OR51E2KDM4ELMNA | |
| SCHEMBL2586658 | 0.97 | GLRA1 (0.37) | GLRA1SLC6A9OR51E2KDM4ELMNA | |
| SCHEMBL6237274 | 0.97 | GLRA1 (0.37) | GLRA1SLC6A9OR51E2KDM4ELMNA | |
| SCHEMBL583140 | 0.97 | GLRA1 (0.37) | GLRA1SLC6A9OR51E2KDM4ELMNA | |
| SCHEMBL16602 | 0.97 | GLRA1 (0.37) | GLRA1SLC6A9OR51E2KDM4ELMNA | |
| SCHEMBL25362121 | 0.97 | GLRA1 (0.37) | GLRA1SLC6A9OR51E2KDM4ELMNA | |
| SCHEMBL1666322 | 0.97 | GLRA1 (0.37) | GLRA1SLC6A9OR51E2KDM4ELMNA | |
| Hydrochloric Acid SCHEMBL22518913 | 0.91 | KDM4E (0.34) | GLRA1SLC6A9OR51E2KDM4ELMNA | |
| SCHEMBL288431 | 0.86 | — | — | |
| SCHEMBL9765913 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119797313-A | Method for preparing double-carbon modified sodium-electricity positive electrode material by utilizing waste ferric phosphate | 龙子湖新能源实验室 | 2025-04-11 | — | — | CN | claimed |
| CN-115531321-A | Amoxicillin composition, preparation method and application thereof | 广东温氏大华农生物科技有限公司 | 2022-12-30 | — | — | CN | claimed |
| US-10610596-B2 | Methods of making solid vaccine compositions having reduced foaming | ABIC BIOLOGICAL LABORATORIES LTD. (IL) | 2020-04-07 | — | — | US | claimed |
| WO-2019073321-A1 | EFFERVESCENT COMPOSITIONS COMPRISING RIFAXIMIN | ZENVISION PHARMA LLP (IN) | 2019-04-18 | — | — | WO | claimed |
| US-10188734-B2 | Reduced foaming vaccine compositions | MERIAL, INC. (US) | 2019-01-29 | — | — | US | claimed |
| WO-2018193346-A1 | EFFERVESCENT COMPOSITIONS COMPRISING CHLORPROMAZINE OR SALT THEREOF | ZENVISION PHARMA LLP (IN) | 2018-10-25 | — | — | WO | claimed |
| CN-102698277-B | Drug carrier for sustained release of drug | 钟术光 | 2016-08-03 | — | — | CN | claimed |
| WO-2013100871-A1 | EFFERVESCENT RIVASTIGMINE FORMULATIONS | BILGIC MAHMUT (TR) | 2013-07-04 | — | — | WO | claimed |
| CN-101987081-B | Controlled release preparation | SHUGUANG ZHONG | 2012-08-08 | — | — | CN | claimed |
| US-20110268235-A1 | BORON-10 ENHANCED THERMAL ENERGY | GURIN MICHAEL | 2011-11-03 | — | — | US | claimed |
| CN-101987081-A | Controlled release preparation | SHUGUANG ZHONG | 2011-03-23 | — | — | CN | claimed |
| CN-101987082-A | Solid preparation and preparation method thereof | SHUGUANG ZHONG | 2011-03-23 | — | — | CN | claimed |
| CN-100445263-C | Microwave method for synthesizing carbonate of natrium glycine | UNIV SICHUAN (CN) | 2008-12-24 | — | — | CN | claimed |
| US-20070232785-A1 | Process for neutralization of the residual acidity contained in the phenolic compounds | A. WEBER (FR) | 2007-10-04 | — | — | US | claimed |
| EP-1088052-A1 | USE OF CARBON DIOXIDE AND CARBONIC ACID TO CLEAN CONTACT LENSES | Alcon Laboratories, Inc. (US) | 2001-04-04 | — | — | EP | claimed |
| US-6171404-B1 | DISINFECTING HYDROGEN PEROXIDE IN EFFERVESCENT TABLETS FOR CONTACT LENSES | ALCON LABORATORIES, INC. | 2001-01-09 | — | — | US | claimed |
| WO-1999066020-A1 | USE OF CARBON DIOXIDE AND CARBONIC ACID TO CLEAN CONTACT LENSES | ALCON LABORATORIES, INC. (US) | 1999-12-23 | — | — | WO | claimed |
| US-5909745-A | EXCLUSION OF POLYMERIC BEADS, ENZYMES, SURFACTNATS AND HYDROGEN PEROXIDE TO REDUCE LIKELINESS OF DAMAGE TO CONTACT LENSE OR EYES | ALCON LABORATORIES, INC. (US) | 1999-06-08 | — | — | US | claimed |
| EP-0293975-B1 | DRY, RAPIDLY SOLUBLE, COMPOSITIONS OF BETA-LACTAM ANTIBIOTICS | AKZO N.V. (NL) | 1991-07-24 | — | — | EP | claimed |
| EP-0063884-B1 | OXAZOLE DERIVATIVES, THEIR PREPARATION AND USE | JOHN WYETH & BROTHER LIMITED (GB) | 1985-06-26 | — | — | EP | claimed |